These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 25711936)
1. Fluoxetine and S-citalopram inhibit M1 activation and promote M2 activation of microglia in vitro. Su F; Yi H; Xu L; Zhang Z Neuroscience; 2015 May; 294():60-8. PubMed ID: 25711936 [TBL] [Abstract][Full Text] [Related]
2. Fluoxetine and citalopram decrease microglial release of glutamate and D-serine to promote cortical neuronal viability following ischemic insult. Dhami KS; Churchward MA; Baker GB; Todd KG Mol Cell Neurosci; 2013 Sep; 56():365-74. PubMed ID: 23876875 [TBL] [Abstract][Full Text] [Related]
3. Fluoxetine and citalopram exhibit potent antiinflammatory activity in human and murine models of rheumatoid arthritis and inhibit toll-like receptors. Sacre S; Medghalchi M; Gregory B; Brennan F; Williams R Arthritis Rheum; 2010 Mar; 62(3):683-93. PubMed ID: 20131240 [TBL] [Abstract][Full Text] [Related]
4. The antidepressant fluoxetine but not citalopram suppresses synapse formation and synaptic transmission between Lymnaea neurons by perturbing presynaptic and postsynaptic machinery. Getz A; Xu F; Zaidi W; Syed NI Eur J Neurosci; 2011 Jul; 34(2):221-34. PubMed ID: 21722207 [TBL] [Abstract][Full Text] [Related]
5. Fluoxetine and its metabolite norfluoxetine induce microglial apoptosis. Dhami KS; Churchward MA; Baker GB; Todd KG J Neurochem; 2019 Mar; 148(6):761-778. PubMed ID: 30613984 [TBL] [Abstract][Full Text] [Related]
6. Differential modulation of Nav1.7 and Nav1.8 channels by antidepressant drugs. Thériault O; Poulin H; Beaulieu JM; Chahine M Eur J Pharmacol; 2015 Oct; 764():395-403. PubMed ID: 26187311 [TBL] [Abstract][Full Text] [Related]
7. A common mechanism of action of the selective serotonin reuptake inhibitors citalopram and fluoxetine: reversal of chronic psychosocial stress-induced increase in CRE/CREB-directed gene transcription in transgenic reporter gene mice. Böer U; Noll C; Cierny I; Krause D; Hiemke C; Knepel W Eur J Pharmacol; 2010 May; 633(1-3):33-8. PubMed ID: 20122921 [TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory effects of fluoxetine in lipopolysaccharide(LPS)-stimulated microglial cells. Liu D; Wang Z; Liu S; Wang F; Zhao S; Hao A Neuropharmacology; 2011 Sep; 61(4):592-9. PubMed ID: 21575647 [TBL] [Abstract][Full Text] [Related]
9. The pharmacogenetics of the selective serotonin reuptake inhibitors. Brøsen K Clin Investig; 1993 Dec; 71(12):1002-9. PubMed ID: 8124052 [TBL] [Abstract][Full Text] [Related]
11. Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies. Mansari ME; Wiborg O; Mnie-Filali O; Benturquia N; Sánchez C; Haddjeri N Int J Neuropsychopharmacol; 2007 Feb; 10(1):31-40. PubMed ID: 16448580 [TBL] [Abstract][Full Text] [Related]
12. Neurokinin1 antagonists potentiate antidepressant properties of serotonin reuptake inhibitors, yet blunt their anxiogenic actions: a neurochemical, electrophysiological, and behavioral characterization. Gobert A; Brocco M; Dekeyne A; Di Cara B; Bouchez G; Lejeune F; Gannon RL; Millan MJ Neuropsychopharmacology; 2009 Mar; 34(4):1039-56. PubMed ID: 18830239 [TBL] [Abstract][Full Text] [Related]
13. Essential Contributions of Serotonin Transporter Inhibition to the Acute and Chronic Actions of Fluoxetine and Citalopram in the SERT Met172 Mouse. Nackenoff AG; Moussa-Tooks AB; McMeekin AM; Veenstra-VanderWeele J; Blakely RD Neuropsychopharmacology; 2016 Jun; 41(7):1733-41. PubMed ID: 26514584 [TBL] [Abstract][Full Text] [Related]
14. Are pharmacokinetic drug interactions with the SSRIs an issue? Brøsen K Int Clin Psychopharmacol; 1996 Mar; 11 Suppl 1():23-7. PubMed ID: 8732441 [TBL] [Abstract][Full Text] [Related]
15. Effects of citalopram and fluoxetine on the corticocerebral blood flow in conscious rabbits. Sas K; Csete K; Vezekényi Z; Sztriha L; Vécseil L; Papp JG Acta Physiol Hung; 2007 Sep; 94(3):167-77. PubMed ID: 17853768 [TBL] [Abstract][Full Text] [Related]
17. Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans. Warner-Schmidt JL; Vanover KE; Chen EY; Marshall JJ; Greengard P Proc Natl Acad Sci U S A; 2011 May; 108(22):9262-7. PubMed ID: 21518864 [TBL] [Abstract][Full Text] [Related]
18. From selective to highly selective SSRIs: a comparison of the antinociceptive properties of fluoxetine, fluvoxamine, citalopram and escitalopram. Schreiber S; Pick CG Eur Neuropsychopharmacol; 2006 Aug; 16(6):464-8. PubMed ID: 16413173 [TBL] [Abstract][Full Text] [Related]
19. Effects of repeated fluoxetine and citalopram administration on cytokine release in C57BL/6 mice. Kubera M; Simbirtsev A; Mathison R; Maes M Psychiatry Res; 2000 Nov; 96(3):255-66. PubMed ID: 11084221 [TBL] [Abstract][Full Text] [Related]
20. Dose-dependent influence of buspirone on the activities of selective serotonin reuptake inhibitors in the mouse forced swimming test. Redrobe JP; Bourin M Psychopharmacology (Berl); 1998 Jul; 138(2):198-206. PubMed ID: 9718290 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]